Tokyo, Japan

Shunichi Nakamaru

This inventor holds 1 USPTO granted patent. Top assignee: Toray Industries, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shunichi Nakamaru. Retrieved from https://idiyas.com/inventor/shunichi-nakamaru

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shunichi Nakamaru: Innovator in Biological Signal Measurement

Introduction

Shunichi Nakamaru is a prominent inventor based in Tokyo, Japan. He is known for his innovative contributions to the field of biological signal measurement. His work has significant implications for health monitoring and wearable technology.

Latest Patents

Shunichi Nakamaru holds a patent for a "Wear for measuring biological signal." This invention showcases his commitment to advancing technology that can enhance personal health management.

Career Highlights

Nakamaru is currently employed at Toray Industries, Inc., a leading company in advanced materials and technologies. His role at Toray has allowed him to focus on developing cutting-edge solutions in the field of biological signal measurement.

Collaborations

He has collaborated with notable colleagues, including Ichiro Itagaki and Hirokazu Sugihara. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Shunichi Nakamaru's work exemplifies the spirit of innovation in the realm of wearable technology and health monitoring. His contributions are paving the way for future advancements in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…